Insider Trading Summary for Myriad Genetics Inc. (MYGN): Year

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
02-Jun-23 6:00 PM View:	01-Jun-23 Grant 0	Phanstiel S. Louise Director		Myriad Genetics Inc. - MYGN	12% 129.92K to 145.07K	0	0	--	--	Show Txns Hide Txns

05-Dec-23 4:19 PM View:	01-Dec-23 Sale (Planned) ($572.84K)	Riggsbee Richard Bryan Chief Financial Officer		Myriad Genetics Inc. - MYGN	(21%) 368.67K to 291.81K	0	0	--	--	Show Txns Hide Txns

02-Jun-23 6:07 PM View:	01-Jun-23 Grant 0	Newcomer Lee Nisley Director		Myriad Genetics Inc. - MYGN	26% 57.7K to 72.85K	0	0	--	--	Show Txns Hide Txns

02-Jun-23 6:11 PM View:	01-Jun-23 Grant 0	Reitan Colleen F Director		Myriad Genetics Inc. - MYGN	26% 57.7K to 72.85K	0	0	--	--	Show Txns Hide Txns

02-Jun-23 6:15 PM View:	02-Jun-23 Sale (Planned) ($198.76K)	Spiegelman Daniel K Director		Myriad Genetics Inc. - MYGN	19% 33.98K to 40.49K	0	0	--	--	Show Txns Hide Txns

02-Jun-23 6:17 PM View:	01-Jun-23 Grant 0	Skovronsky Daniel Director		Myriad Genetics Inc. - MYGN	27% 55.16K to 70.31K	0	0	--	--	Show Txns Hide Txns

02-Jun-23 6:20 PM View:	01-Jun-23 Grant 0	Kumar Rashmi Director		Myriad Genetics Inc. - MYGN	28% 54.05K to 69.2K	0	0	--	--	Show Txns Hide Txns

25-Mar-24 4:31 PM View:	24-Mar-24 Payment of Exercise ($64.27K)	Haas Kevin Richard Chief Technology Officer		Myriad Genetics Inc. - MYGN	22% 108.25K to 132.1K	0	0	--	--	Show Txns Hide Txns

25-Mar-24 4:32 PM View:	22-Mar-24 Payment of Exercise ($32.05K)	Wong Pamela Chief Legal Officer		Myriad Genetics Inc. - MYGN	(10%) 72.32K to 65.0K	0	0	--	--	Show Txns Hide Txns

10-Oct-23 4:19 PM View:	09-Oct-23 Payment of Exercise ($181.79K)	Lambert Nicole Chief Operating Officer		Myriad Genetics Inc. - MYGN	(7%) 240.51K to 223.99K	0	0	--	--	Show Txns Hide Txns

25-Mar-24 4:30 PM View:	24-Mar-24 Payment of Exercise ($1.02M)	Diaz Paul J President and CEO Director		Myriad Genetics Inc. - MYGN	6% 1.22M to 1.29M	0	0	--	--	Show Txns Hide Txns

15-Apr-24 4:25 PM View:	14-Apr-24 Payment of Exercise ($21.04K)	Verratti Mark Chief Commercial Officer		Myriad Genetics Inc. - MYGN	14% 262.7K to 298.71K	0	0	--	--	Show Txns Hide Txns

15-Apr-24 4:27 PM View:	14-Apr-24 Payment of Exercise ($18.38K)	Muzzey Dale Chief Scientific Officer		Myriad Genetics Inc. - MYGN	61% 68.22K to 110.11K	0	0	--	--	Show Txns Hide Txns

02-Jun-23 6:05 PM View:	01-Jun-23 Grant 0	Dreismann Heiner Director		Myriad Genetics Inc. - MYGN	15% 100.8K to 115.95K	0	0	--	--	Show Txns Hide Txns

08-Apr-24 4:49 PM View:	06-Apr-24 Payment of Exercise ($11.77K)	Munk Natalie Chief Accounting Officer		Myriad Genetics Inc. - MYGN	51% 29.45K to 44.44K	0	0	--	--	Show Txns Hide Txns

02-Jun-23 6:21 PM View:	01-Jun-23 Grant 0	Bisaro Paul Director		Myriad Genetics Inc. - MYGN	45% 16.88K to 24.45K	0	0	--	--	Show Txns Hide Txns

25-Mar-24 4:31 PM View:	22-Mar-24 Payment of Exercise ($16.24K)	Ancona Margaret SVP, Chief of Staff		Myriad Genetics Inc. - MYGN	81% 50.27K to 90.9K	0	0	--	--	Show Txns Hide Txns

18-Mar-24 4:45 PM View:	14-Mar-24 Grant 0	Solaiman Shereen Chief People Officer		Myriad Genetics Inc. - MYGN	252% 15.86K to 55.79K	0	0	--	--	Show Txns Hide Txns

18-Mar-24 4:44 PM View:	14-Mar-24 Grant 0	Raha Samraat S. Chief Operating Officer		Myriad Genetics Inc. - MYGN	100% 0 to 300.85K	0	0	--	--	Show Txns Hide Txns

18-Mar-24 4:44 PM View:	14-Mar-24 Grant 0	Leffler Scott J. Chief Financial Officer		Myriad Genetics Inc. - MYGN	100% 0 to 163.87K	0	0	--	--	Show Txns Hide Txns

Myriad Genetics Inc. (MYGN)

Last Year

02-May-23 -- 01-May-24

Company Sentiment

Diagnostic Substances

Drugs

Two Year Chart

02-May-22 -- 01-May-24

Price ($)

Sentiment

Buy & Sell Volume ($)

Recent Insider Trades

Buy:	0	--
Sell:	0	--